Neurorehabilitation News

In this video perspective, Igor J. Koralnik, MD, FAAN, FANA, reviews his talk on COVID-19 immunology and COVID-19 vaccines from the COVID-19 plenary session at the American Academy of Neurology annual meeting, which is being held virtually.

Findings from a prospective cohort study of patients with mild traumatic brain injury demonstrated that women were more likely than men to experience persistent cognitive and somatic symptoms related to the injury.

Two patients enrolled in a COVID-19 vaccine trial — including one who received the vaccine and one who received placebo — developed Guillain-Barré syndrome 10 days after the injection, according to a case report published in Neurology.

Non-hospitalized ‘long hauler’ patients with COVID-19 experienced “prominent and persistent” neurological symptoms, including brain fog and fatigue, according to results published in Annals of Clinical and Translational Neurology.

Today marks the inaugural celebration of World Coma Day, a daylong, online event organized by the Neurocritical Care Society designed to raise awareness of coma as a clinical event that can be treated and cured.

Children and young adults who experience post-traumatic headache with migraine phenotype may be at increased risk for more significant injury or deleterious pathophysiology after concussion.

Most individuals who became comatose after moderate or severe traumatic brain injury regained consciousness, including those who regained consciousness during rehabilitation, according to findings from a cohort study.

A longitudinal study quantifying neuroplasticity in the ipsilesional and contralesional human motor cortex following a stroke demonstrated “a period of enhanced synaptic plasticity” that was strongest about 2 weeks after the event.

Intensive arm motor therapy improved modified Rankin Scale scores among a “substantial” portion of patients who had experienced a stroke, according to findings published in Neurology.

An update to the Bioness Integrated Therapy System, or BITS, called BITS Balance will provide the medical community with another tool for evaluating patients in neurorehabilitation — including patients recovering from COVID-19.